These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 17214375)

  • 1. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
    Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a tumour suppressive function of E2F1 gene in human breast cancer.
    Worku D; Jouhra F; Jiang GW; Patani N; Newbold RF; Mokbel K
    Anticancer Res; 2008; 28(4B):2135-9. PubMed ID: 18751386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a tumour suppressive function of APRG1 in breast cancer.
    Leris AC; Roberts TR; Jiang WG; Newbold RF; Mokbel K
    Breast Cancer Res Treat; 2005 Sep; 93(2):97-100. PubMed ID: 16187228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.
    Suzuki T; Nakata T; Miki Y; Kaneko C; Moriya T; Ishida T; Akinaga S; Hirakawa H; Kimura M; Sasano H
    Cancer Res; 2003 Jun; 63(11):2762-70. PubMed ID: 12782580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer.
    Utsumi T; Yoshimura N; Takeuchi S; Ando J; Maruta M; Maeda K; Harada N
    Cancer Res; 1999 Jan; 59(2):377-81. PubMed ID: 9927050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
    Jiang WG; Douglas-Jones AG; Mansel RE
    Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.
    Miki Y; Suzuki T; Kitada K; Yabuki N; Shibuya R; Moriya T; Ishida T; Ohuchi N; Blumberg B; Sasano H
    Cancer Res; 2006 Jan; 66(1):535-42. PubMed ID: 16397270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer.
    Subramanian A; Sharma AK; Banerjee D; Jiang WG; Mokbel K
    Anticancer Res; 2007; 27(5B):3513-8. PubMed ID: 17972510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
    Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.
    Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer.
    Miyoshi Y; Ando A; Hasegawa S; Ishitobi M; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2003 Jun; 9(6):2288-93. PubMed ID: 12796397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
    Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
    J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC; Wang F; Elliott RL; Head JF
    Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
    Ariazi EA; Clark GM; Mertz JE
    Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
    Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
    Currie MJ; Gunningham SP; Han C; Scott PA; Robinson BA; Harris AL; Fox SB
    Clin Cancer Res; 2001 Apr; 7(4):918-27. PubMed ID: 11309342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.